This is a StreetInsider.com Premium Only Page

Cumberland Pharmaceuticals (CPIX) – Press Releases

Apr 2, 2024 04:05 PM NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS

Mar 5, 2024 04:05 PM Cumberland Pharmaceuticals Reports Annual 2023 Financial Results

Feb 27, 2024 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS

Nov 7, 2023 04:05 PM Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results

Oct 31, 2023 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS

Oct 10, 2023 04:05 PM NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE

Aug 8, 2023 04:05 PM Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023

Aug 1, 2023 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS

Jun 26, 2023 09:00 AM NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS

May 23, 2023 09:00 AM CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

May 15, 2023 09:00 AM CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS

May 9, 2023 04:05 PM Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update

May 2, 2023 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS

Mar 7, 2023 04:23 PM CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022

Feb 28, 2023 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2022 FINANCIAL RESULTS

Nov 8, 2022 04:05 PM Cumberland Pharmaceuticals Reports 41% Revenue Growth

Nov 1, 2022 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS

Nov 1, 2022 09:20 AM CUMBERLAND PHARMACEUTICALS MOVES INTO NEW HEADQUARTERS AT BROADWEST

Aug 9, 2022 04:05 PM Cumberland Pharmaceuticals Reports 14% Revenue Growth

Aug 8, 2022 09:25 AM CUMBERLAND PHARMACEUTICALS REPORTS 2.4M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2021

Aug 2, 2022 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS

Jul 19, 2022 09:25 AM CUMBERLAND PHARMACEUTICALS APPOINTS MARTIN BROWN JR. TO ITS BOARD OF DIRECTORS

May 10, 2022 04:05 PM Cumberland Pharmaceuticals Reports 6% Revenue Growth

May 9, 2022 09:15 AM Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso®

May 3, 2022 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2022 FINANCIAL RESULTS

Mar 31, 2022 09:20 AM TABUK AND CUMBERLAND PARTNER TO BRING INNOVATIVE ANTIBIOTIC WITH LIFE-SAVING POTENTIAL TO MIDDLE EAST

Mar 8, 2022 04:05 PM CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE

Mar 1, 2022 04:05 PM CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2021 FINANCIAL RESULTS

Jan 4, 2022 09:15 AM CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA

Nov 29, 2021 04:05 PM Caldolor® Now FDA Approved For Pre-Operative Administration

Nov 9, 2021 04:05 PM Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update

Nov 2, 2021 04:05 PM Cumberland Pharmaceuticals To Announce Third Quarter 2021 Financial Results

Sep 29, 2021 09:25 AM Cumberland Pharmaceuticals Launches RediTrex® Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psoriatic Arthritis

Aug 10, 2021 04:05 PM Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update

Aug 3, 2021 04:05 PM Cumberland Pharmaceuticals To Announce Second Quarter 2021 Financial Results

Jul 26, 2021 09:25 AM Cumberland Pharmaceuticals Reports 2.5M Patient Doses Delivered, No Product Recalls, No FDA Issues in 2020

Jun 21, 2021 09:20 AM Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients

May 19, 2021 03:30 PM Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer

May 11, 2021 04:05 PM Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update

May 4, 2021 04:05 PM Cumberland Pharmaceuticals To Announce First Quarter 2021 Financial Results

Mar 9, 2021 04:05 PM Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020

Mar 2, 2021 04:05 PM Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results

Nov 17, 2020 11:06 AM Introducing RediTrex®, A New Methotrexate Delivery System

Nov 10, 2020 04:05 PM Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update

Nov 3, 2020 04:05 PM Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results

Aug 18, 2020 09:35 AM Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use

Aug 11, 2020 04:05 PM Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update

Aug 4, 2020 04:05 PM Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results

Jul 20, 2020 08:35 AM Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients

May 26, 2020 04:05 PM New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis